(Q31923969)

5 July 2017

SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity (English)

1 reference

5 July 2017

1 reference

1 reference

Muralikrishnan D

1

1 reference

PubMed ID

11172770

5 July 2017

Ebadi M

series ordinal

2

1 reference

PubMed ID

11172770

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

5 July 2017

892

1 reference

5 July 2017

2

1 reference

5 July 2017

241-247

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

5 July 2017

1 reference

Brain Peroxidase and Catalase in Parkinson Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Differential effects of three dopamine receptor agonists in MPTP-treated monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Bromocriptine in Parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

A fluorometric assay for glutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Oxidative stress and antioxidant therapy in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Nitric oxide, mitochondria and neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Oxidative stress and the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Etiology and pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Parkinson's disease: a disorder due to nigral glutathione deficiency?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Antiparkinsonian therapies and brain mitochondrial complex I activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Effect of MPTP and l‐Deprenyl on Antioxidant Enzymes and Lipid Peroxidation Levels in Mouse Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Dopamine receptors and sensorimotor behavior in MPTP-treated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902994-2

10.1016/S0006-8993(00)02994-2

7 January 2021

Identifiers

DOI

1 reference

5 July 2017

1 reference

PubMed ID

11172770